Elucidation and synthesis of selected pentapeptides
AssigneeArizona Board of Regents
InventorsGeorge R. Pettit, Jayaram K. Srirangam
Life of this patent
Estimating the term…
Abstract
The sea hare Dolabella auricularia has yielded many structurally distinct peptides which possess antineoplastic activity. Presently the compound denominated "dolastatin 10" represents the most important of such peptides because of its demonstrated potential as an anticancer drug. The present invention relates to the systematic creation of five unique pentapeptides by selectively coupling a tripeptide-trifluoroacetate salt with a preselected dipeptide-trifluoroacetate salt which provide active molecules capable of emulating the measured therapeutic effect of dolastatin 10. The pentapeptides hereof have the structure shown below: ##STR1## wherein R is selected from the following group of substituents: ##STR2##
Claims19
A composition of matter having the structural formula designated 3(a-e):
- ##STR5## wherein R is selected from the following group of substituents:
- ##STR6##
A method for inhibiting the growth of human cancer cells wherein said cancer is selected from the group consisting of leukemia, ovarian cancer, CNS cancer, mammary cancer, non-small cell lung cancer, renal cancer, colon cancer, and melanoma consisting of administering an active ingredient selected from the group consisting of:
- Dov-Val-Dil-Dap-Phe-OCH.sub.3, Dov-Val-Dil-Dap-Phe-NH.sub.2, Dov-Val-Dil-Dap-Pro-OCH.sub.3, Dov-Val-Dil-Dap-Ile-OCH.sub.3, and Dov-Val-Dil-Dap-Met-OCH.sub.3, to said cells in a quantity sufficient to inhibit the growth of said cells.
Dependencies are inferred from the claim text.